Summary
The plaintiff sued for breach of contracts relating to ProPharma’s offer to have Donnelly join the board in 2016 and for not paying him for his incentive equity shares, implemented in 2017, at fair market value. Each side engaged an experienced business valuation expert to opine as to the fair market value of the equity shares. Each side now moved to exclude the testimony of the other side’s expert. The U.S. District Court for the District of Delaware denied the motions of both sides and allowed both experts to testify.
See Also
Donnelly v. ProPharma Grp. Topco LLC
The plaintiff sued for breach of contracts relating to ProPharma’s offer to have Donnelly join the board in 2016 and for not paying him for his incentive equity shares, implemented in 2017, at fair market value. Each side engaged an experienced business valuation expert to opine as to the fair market value of the equity shares. Each side now moved to exclude the testimony of the other side’s expert. The U.S. District Court for the District of Delaware denied the motions of both sides and allowed both experts to testify.